TrademarkDir
BLACK SWAN RESEARCH INITIATIVE
LIVE

Serial Number

85877861

Owner

International Myeloma Foundation

Attorney

Natasha Shabani

First Use Date

Apr 15, 2013

Filing Date

Mar 15, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BLACK SWAN RESEARCH INITIATIVE Trademark

Serial Number: 85877861 • Registration: 4486336

BLACK SWAN RESEARCH INITIATIVE is a trademark filed by International Myeloma Foundation on March 15, 2013. The trademark is classified under Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

International Myeloma Foundation (85 trademarks)

Suite 206
North Hollywood, CA 91607

Entity Type: 99

Trademark Details

Filing Date

March 15, 2013

Registration Date

February 18, 2014

First Use Anywhere

April 15, 2013

First Use in Commerce

April 14, 2013

Published for Opposition

August 27, 2013

Goods & Services

Booklets in the field of treatment, care, management, prevention, research and cure of multiple myeloma; Printed educational materials in the field of treatment, care, management, prevention, research and cure of multiple myeloma; Printed periodicals in the field of treatment, care, management, prevention, research and cure of multiple myeloma; Publications, namely, brochures, booklets, and teaching materials in the field of treatment, care, management, prevention, research and cure of multiple myeloma

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 31, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 31, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 31, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 31, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 3, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 18, 2023 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 26, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 26, 2022 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 30, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 30, 2019 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 20, 2019 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 4, 2019 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 29, 2019 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 7, 2019 TCCA
TEAS SECTION 8 & 15 RECEIVED
Aug 7, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 18, 2019 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2018 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2014 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 11, 2014 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 10, 2014 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 9, 2014 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 19, 2013 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2013 AITU
USE AMENDMENT FILED
Nov 10, 2013 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 10, 2013 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 22, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2013 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 25, 2013 PREV
ASSIGNED TO LIE
Jul 25, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 4, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 4, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 4, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 4, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 4, 2013 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jul 1, 2013 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2013 NWOS
NEW APPLICATION ENTERED
Mar 19, 2013 NWAP

Related Trademarks

More from this Owner

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMF USMN

IMF USMN

IMF USMN

IMF USMN

USMN

USMN

IMF USMN

IMF USMN